DNMT3A and acute lymphoblastic leukemia: In general, DNMT3A-mutant T-ALL showed similar sensitivity to most chemotherapeutics compared with patient samples with wild-type DNMT3A but were resistant to apoptosis induced by doxorubicin and dexamethasone (DEX; Figure 5C).